- Rojo, A.I.; Buttari, B.; Cadenas, S.; Carlos, A.R.; Cuadrado, A.; Falcão, A.S.; López, M.G.; Georgiev, M.I.; Grochot-Przeczek, A.; Gumeni, S.; Jiménez-Villegas, J.; Horbanczuk, J.O.; Konu, O.; Lastres-Becker, I.; Levonen, A.L.; Maksimova, V.; Michaeloudes, C.; Mihaylova, L.V.; Mickael, M.E.; Milisav, I.; Miova, B.; Rada, P.; Santos, M.; Seabra, M.C.; Strac, D.S.; Tenreiro, S.; Trougakos, I.P.; Dinkova-Kostova, A.T. "Corrigendum to "Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases" [Redox Biol. 79 (2025) 103464].". Redox Biol. (): 103496. (2025). (PMID: 39833011).
  
- Carnicero-Senabre, D.; Jiménez-Villegas, J.; Álvarez-Garrote, S.; Escoll, M.; Cuadrado, A.; Rojo, A.I. "NRF2 activation by 6-MSITC increases the generation of neuroprotective, soluble α amyloid precursor protein by inducing the metalloprotease gene ADAM17.". Free Radic Biol Med. (): . (2024). (PMID: 39613049).
- Fernández-Ginés, R.; Encinar, J.A.; Escoll, M.; Carnicero-Senabre, D.; Jiménez-Villegas, J.; García-Yagüe, Á.J.; González-Rodríguez, Á.; Garcia-Martinez, I.; M Valverde, Á.; Rojo, A.I.; Cuadrado, A. "Specific targeting of the NRF2/β-TrCP axis promotes beneficial effects in NASH.". Redox Biol. 69(): 103027. (2024). (PMID: 38184999).
- Silva-Llanes, I.; Shin, C.H.; Jiménez-Villegas, J.; Gorospe, M.; Lastres-Becker, I. "The Transcription Factor NRF2 Has Epigenetic Regulatory Functions Modulating HDACs, DNMTs, and miRNA Biogenesis.". Antioxidants (Basel). 12(3): . (2023). (PMID: 36978889).
- Jiménez-Villegas, J.; Kirby, J.; Mata, A.; Cadenas, S.; Turner, M.R.; Malaspina, A.; Shaw, P.J.; Cuadrado, A.; Rojo, A.I. "Dipeptide Repeat Pathology in C9orf72-ALS Is Associated with Redox, Mitochondrial and NRF2 Pathway Imbalance.". Antioxidants (Basel). 11(10): . (2022). (PMID: 36290620).
- Milanesi, E.; Dobre, M.; Cucos, C.A.; Rojo, A.I.; Jiménez-Villegas, J.; Capetillo-Zarate, E.; Matute, C.; Piñol-Ripoll, G.; Manda, G.; Cuadrado, A. "Whole Blood Expression Pattern of Inflammation and Redox Genes in Mild Alzheimer's Disease.". J Inflamm Res. 14(): 6085-6102. (2021). (PMID: 34848989).
- Jiménez-Villegas, J.; Ferraiuolo, L.; Mead, R.J.; Shaw, P.J.; Cuadrado, A.; Rojo, A.I. "NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS.". Free Radic Biol Med. 173(): 125-141. (2021). (PMID: 34314817).
- Cuadrado, A.; Pajares, M.; Benito, C.; Jiménez-Villegas, J.; Escoll, M.; Fernández-Ginés, R.; Garcia Yagüe, A.J.; Lastra, D.; Manda, G.; Rojo, A.I.; Dinkova-Kostova, A.T. "Can Activation of NRF2 Be a Strategy against COVID-19?". Trends Pharmacol. Sci.. (): . (2020). (PMID: 32711925).
|
Email:Info